BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 21098287)

  • 1. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
    Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
    Liu R; Zhou XW; Tanila H; Bjorkdahl C; Wang JZ; Guan ZZ; Cao Y; Gustafsson JA; Winblad B; Pei JJ
    J Cell Mol Med; 2008; 12(1):241-57. PubMed ID: 18208556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex.
    Schweiger S; Matthes F; Posey K; Kickstein E; Weber S; Hettich MM; Pfurtscheller S; Ehninger D; Schneider R; Krauß S
    Sci Rep; 2017 Oct; 7(1):13753. PubMed ID: 29062069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau.
    Meske V; Albert F; Ohm TG
    J Biol Chem; 2008 Jan; 283(1):100-109. PubMed ID: 17971449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
    Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
    J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.
    Pérez-Revuelta BI; Hettich MM; Ciociaro A; Rotermund C; Kahle PJ; Krauss S; Di Monte DA
    Cell Death Dis; 2014 May; 5(5):e1209. PubMed ID: 24810045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation.
    Li Y; Wang X; Yue P; Tao H; Ramalingam SS; Owonikoko TK; Deng X; Wang Y; Fu H; Khuri FR; Sun SY
    J Biol Chem; 2013 May; 288(19):13215-24. PubMed ID: 23536185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
    Arif M; Kazim SF; Grundke-Iqbal I; Garruto RM; Iqbal K
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1144-9. PubMed ID: 24395787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
    Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
    Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
    Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B.
    Luo Y; Nie YJ; Shi HR; Ni ZF; Wang Q; Wang JZ; Liu GP
    Biochim Biophys Acta; 2013 May; 1833(5):1235-43. PubMed ID: 23428800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
    Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
    J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
    Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.
    Tang Z; Bereczki E; Zhang H; Wang S; Li C; Ji X; Branca RM; Lehtiö J; Guan Z; Filipcik P; Xu S; Winblad B; Pei JJ
    J Biol Chem; 2013 May; 288(22):15556-70. PubMed ID: 23585566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.
    Arribas RL; Viejo L; Bravo I; Martínez M; Ramos E; Romero A; García-Frutos EM; Janssens V; Montiel C; de Los Ríos C
    Eur J Med Chem; 2023 May; 251():115245. PubMed ID: 36905916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound C enhances tau phosphorylation at Serine
    Majd S; Koblar S; Power J
    Neurosci Lett; 2018 Mar; 670():53-61. PubMed ID: 29398519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
    Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
    J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
    Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
    Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.